Dorman Products (DORM) Q2 2026 Earnings Call Transcript

Dorman Products posted Q2 net sales of $544.6M (+0.7% YoY) and record adjusted diluted EPS of $3.08 (+50% YoY), helped by a $1.18/share recovery of previously recognized IEEPA tariff costs. The company raised FY2026 adjusted EPS guidance to $8.50–$8.80 (+$0.30 at the top end vs. prior), while cutting net sales growth guidance to 3%–5% (from 7%–9%) as it passes through lower ongoing tariff costs. Operating margin expanded 600bps to 22.3% in the quarter and free cash flow rebounded to $144M, with $47M used for buybacks (398k shares at ~$118) after refinancing that left net debt at ~$318M and liquidity at $931M.

Analysis

The real signal is not the reported EPS beat; it is that DORM is willingly giving back pricing to preserve channel economics while keeping volumes intact. That is usually a share-taking move, not a margin story: if lower shelf prices convert even a fraction of DIY hesitation into DIFM/retailer sell-through, the company can trade near-term revenue compression for a stronger 2027 base. The flip side is that the current quarter’s economics are overstated by the refund, so investors anchoring on headline margin may be overestimating run-rate power by roughly 300-400 bps.

Winners are the downstream distribution layer and any aftermarket peers with more DIY exposure, because lower parts prices should stabilize basket demand and reduce substitution to repair deferral. Losers are smaller niche suppliers and private-label players that lack DORM’s balance-sheet flexibility and product-development cadence; they are less able to absorb tariff normalization without sacrificing share. In heavy-duty, the more interesting second-order effect is that dealer service centers become a larger battleground as new-vehicle sales soften; that can support DORM’s channel mix even before freight volumes recover.

Catalyst path: 1-3 months, the stock likely trades on whether 2H unit growth actually offsets pricing. If management fails to show mid-single-digit volume acceleration or if comparable gross margin does not approach ~40% by Q4, the market will re-rate the name down from a refund-driven peak. Over 6-18 months, the thesis depends on whether new product wins and M&A convert the cleaner tariff setup into durable mid-teens operating margins. Contrarian view: consensus may be too focused on the lower FY sales guide and not enough on the fact that lower tariffs improve cash conversion and optionality for buybacks/M&A; that said, the move is overdone if investors treat the refund as recurring.

Key Decisions for Investors

• Buy DORM on weakness over the next 1-2 sessions; use a 3-6 month horizon and look for a re-rate as the market shifts from headline EPS to normalized 2027 earnings power. Falsify if 3Q comparable gross margin stays below ~38% or management cuts the 2H volume outlook again.
• Pair trade: long DORM / short AAP for 1-3 months. Thesis is DORM’s DIFM-heavy, nondiscretionary mix and better balance sheet versus AAP’s higher DIY sensitivity and weaker pricing power. Cover if AAP shows surprise unit recovery or DORM’s lower pricing fails to lift sell-through.
• If the stock spikes on the refund optics, fade it with a short-dated DORM call spread or put spread expiring after the next quarter update. The setup is that headline margins are not repeatable; risk is that management proves the pricing reset is already being offset by unit growth.
• Watch ORLY and GPC as downstream beneficiaries rather than immediate shorts; if DORM’s lower pricing drives sell-through, the distribution layer may quietly gain traffic and mix, making it a better relative long than DORM in the first 1-3 months.